Cullen/Frost Bankers’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.9K Buy
1,076
+166
+18% +$4.62K ﹤0.01% 977
2026
Q1
$17K Buy
+910
New +$17.4K ﹤0.01% 1022
2024
Q1
– Sell
-3,835
Closed -$120K – 1089
2023
Q4
$120K Hold
3,835
– – ﹤0.01% 547
2023
Q3
$154K Hold
3,835
– – ﹤0.01% 542
2023
Q2
$202K Hold
3,835
– – ﹤0.01% 499
2023
Q1
$245K Hold
3,835
– – ﹤0.01% 473
2022
Q4
$186K Hold
3,835
– – ﹤0.01% 509
2022
Q3
$271K Hold
3,835
– – 0.01% 459
2022
Q2
$272K Buy
3,835
+5
+0.1% +$322 0.01% 465
2022
Q1
$306K Sell
3,830
-3,685
-49% -$274K 0.01% 466
2021
Q4
$686K Sell
7,515
-315
-4% -$33.8K 0.01% 354
2021
Q3
$1.01M Sell
7,830
-220
-3% -$30.8K 0.02% 301
2021
Q2
$1.23M Buy
8,050
+315
+4% +$41.5K 0.02% 285
2021
Q1
$815K Hold
7,735
– – 0.02% 330
2020
Q4
$613K Hold
7,735
– – 0.01% 339
2020
Q3
$437K Buy
7,735
+600
+8% +$32.3K 0.01% 353
2020
Q2
$439K Buy
+7,135
New +$291K 0.01% 348

Other funds holding STAA

Cullen/Frost Bankers's STAA Position: Q2 2026 in Review

Cullen/Frost Bankers increased its STAAR Surgical (STAA) stake by 18% in Q2 2026, buying an estimated $4.62K and bringing the position to 1,076 shares worth $30.9K. The position accounts for ﹤0.01% of the portfolio, ranked #977.

Cullen/Frost Bankers first reported a position in STAA in Q2 2020 and has held it in 17 quarters since. The position peaked at $1.23M in Q2 2021. 201 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • Cullen/Frost Bankers held 1,076 shares of STAAR Surgical worth $30.9K as of Q2 2026.
  • Cullen/Frost Bankers bought 166 STAAR Surgical shares in Q2 2026, an estimated $4.62K.
  • STAAR Surgical made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #977 holding.
  • Cullen/Frost Bankers first reported a position in STAAR Surgical in Q2 2020 and has held it in 17 quarters since.
  • Cullen/Frost Bankers's STAAR Surgical position peaked at $1.23M in Q2 2021.
  • 201 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.